Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 5
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 4, 2008
Brain abscess as a manifestation of spinal dermal sinus
Parisa Emami-Naeini, Ali Mahdavi, Hamed Ahmadi, Nima Baradaran, Farideh Nejat
Therapeutics and Clinical Risk Management 2008, 4:1143-1147
Published Date: 10 October 2008
Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides
Debra L Breneman, Timothy J Storer, John C Breneman, Diya F Mutasim
Therapeutics and Clinical Risk Management 2008, 4:1135-1141
Published Date: 10 October 2008
A pilot feasibility study of daily rTMS to modify corticospinal excitability during lower limb immobilization
Raffaella Ricci, Dave Ramsey, Kevin Johnson, Jeffrey J Borckardt, Matthew Vallejo, et al
Therapeutics and Clinical Risk Management 2008, 4:1127-1134
Published Date: 10 October 2008
Should patients set the agenda for informed, consent? A prospective survey of desire for information and discussion prior to routine cataract surgery
Lee Teak Tan, Huw Jenkins, John Roberts-Harry, Michael Austin
Therapeutics and Clinical Risk Management 2008, 4:1119-1125
Published Date: 10 October 2008
Analysis of clinical records of dental patients attending Jordan University Hospital: Documentation of drug prescriptions and local anesthetic injections
Najla Dar-Odeh, Soukaina Ryalat, Mohammad Shayyab, Osama Abu-Hammad
Therapeutics and Clinical Risk Management 2008, 4:1111-1117
Published Date: 10 October 2008
Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
V Nicosia, Giorgio Colombo, M Consentino, S Di Matteo, F Mika, et al
Therapeutics and Clinical Risk Management 2008, 4:1105-1110
Published Date: 10 October 2008
Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials
Kyoko Taku, Keizo Umegaki, Yoshiko Ishimi, Shaw Watanabe
Therapeutics and Clinical Risk Management 2008, 4:1097-1103
Published Date: 10 October 2008
Bowen’s disease – a review of newer treatment options
Thorsten Neubert, Percy Lehmann
Therapeutics and Clinical Risk Management 2008, 4:1085-1095
Published Date: 10 October 2008
Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis
Susan S Baker
Therapeutics and Clinical Risk Management 2008, 4:1079-1084
Published Date: 10 October 2008
Optimizing prophylactic treatment of migraine: Subtypes and patient matching
Michel Dib
Therapeutics and Clinical Risk Management 2008, 4:1061-1078
Published Date: 10 October 2008
Weekly docetaxel in the treatment of metastatic breast cancer
Laura Palmeri, Marina Vaglica, Sergio Palmeri
Therapeutics and Clinical Risk Management 2008, 4:1047-1059
Published Date: 10 October 2008
Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release
Mary Ann Werz
Therapeutics and Clinical Risk Management 2008, 4:1035-1046
Published Date: 10 October 2008
Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
Ashish Chandwani, Jonathan Shuter
Therapeutics and Clinical Risk Management 2008, 4:1023-1033
Published Date: 10 October 2008
Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis
Friedrich Horak
Therapeutics and Clinical Risk Management 2008, 4:1009-1022
Published Date: 10 October 2008
Review of docetaxel in the treatment of gastric cancer
Eric D Tetzlaff, Jonathan D Cheng, Jaffer A Ajani
Therapeutics and Clinical Risk Management 2008, 4:999-1007
Published Date: 10 October 2008
Risk management profile of etoricoxib: an example of personalized medicine
Paola Patrignani, Stefania Tacconelli, Marta L Capone
Therapeutics and Clinical Risk Management 2008, 4:983-997
Published Date: 10 October 2008
Treatment of hereditary angioedema with plasma-derived C1 inhibitor
Michael J Prematta, Tracy Prematta, Timothy J Craig
Therapeutics and Clinical Risk Management 2008, 4:975-982
Published Date: 10 October 2008
Management of postoperative ileus: focus on alvimopan
Eric L Marderstein, Conor P Delaney
Therapeutics and Clinical Risk Management 2008, 4:965-973
Published Date: 10 October 2008
New advances in the treatment of Clostridium difficile infection (CDI)
Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K Farver
Therapeutics and Clinical Risk Management 2008, 4:949-964
Published Date: 10 October 2008
Multi-targeted approach in the treatment of thyroid cancer
Scott N Pinchot, Rebecca S Sippel, Herbert Chen
Therapeutics and Clinical Risk Management 2008, 4:935-947
Published Date: 10 October 2008
Treatment of Crohn’s disease with colony-stimulating factors: An overview
Luisa Guidi, Giammarco Mocci, Manuela Marzo, Sergio Rutella
Therapeutics and Clinical Risk Management 2008, 4:927-934
Published Date: 10 October 2008
Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?
Tarsila CR Ribeiro, Julio MF Chebli, Mario Kondo, Pedro Duarte Gaburri, Liliana Andrade Chebli, Ana Cristina Amaral Feldner
Therapeutics and Clinical Risk Management 2008, 4:919-925
Published Date: 10 October 2008
Postoperative ileus: strategies for reduction
James Lubawski, Theodore Saclarides
Therapeutics and Clinical Risk Management 2008, 4:913-917
Published Date: 10 October 2008
Evaluation of extended and continuous use oral contraceptives
Kristen Page Wright, Julia V Johnson
Therapeutics and Clinical Risk Management 2008, 4:905-911
Published Date: 10 October 2008
Pharmacological management of acute bronchiolitis
Melvin Wright, Charles J Mullett, Giovanni Piedimonte
Therapeutics and Clinical Risk Management 2008, 4:895-903
Published Date: 10 October 2008
Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate
Ismail A Mohammed, Alastair J Hutchison
Therapeutics and Clinical Risk Management 2008, 4:887-893
Published Date: 10 October 2008
Docetaxel in the treatment of squamous cell carcinoma of the head and neck
Alexander Rapidis, Nicholas Sarlis, Jean-Louis Lefebvre, Merrill Kies
Therapeutics and Clinical Risk Management 2008, 4:865-886
Published Date: 10 October 2008
Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
Gabriele Nicolini, Nicola Scichilone, Andrea Bizzi, Alberto Papi, Leonardo M Fabbri
Therapeutics and Clinical Risk Management 2008, 4:855-864
Published Date: 10 October 2008
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis
Jessina C McGregor, George P Allen, David T Bearden
Therapeutics and Clinical Risk Management 2008, 4:843-853
Published Date: 10 October 2008